ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy

ClinicalTrials.gov ID: NCT00283842

Public ClinicalTrials.gov record NCT00283842. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, 13-Week, Adaptive-Design Study of 4 Fixed Oral Doses of DVS SR in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy

Study identification

NCT ID
NCT00283842
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Enrollment
408 participants

Conditions and interventions

Interventions

  • DVS SR Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2006
Primary completion
May 31, 2008
Completion
May 31, 2008
Last update posted
Oct 23, 2011

2006 – 2008

United States locations

U.S. sites
51
U.S. states
26
U.S. cities
50
Facility City State ZIP Site status
Not listed Mesa Arizona 85210
Not listed Peoria Arizona 85381
Not listed Phoenix Arizona 85016
Not listed Encino California 91316
Not listed Newport Beach California 92660
Not listed Walnut Creek California 94598
Not listed Pueblo Colorado 81001
Not listed New Britain Connecticut 06050
Not listed Stratford Connecticut 06615
Not listed Waterbury Connecticut 06708
Not listed Fort Myers Florida 33907
Not listed Palm Beach Gardens Florida 33418
Not listed Pembroke Pines Florida 33026
Not listed St. Petersburg Florida 33709
Not listed West Palm Beach Florida 33401
Not listed Lawrenceville Georgia 30045
Not listed Roswell Georgia 30076
Not listed Coeur d'Alene Idaho 83814
Not listed Chicago Illinois 60610
Not listed Evansville Indiana 47714
Not listed Des Moines Iowa 50314
Not listed Madisonville Kentucky 42431
Not listed Springfield Massachusetts 01199
Not listed Ann Arbor Michigan 48106
Not listed Kansas City Missouri 64114
Not listed St Louis Missouri 63117
Not listed St Louis Missouri 63141
Not listed Billings Montana 59101
Not listed Omaha Nebraska 88131
Not listed Albany New York 12205
Not listed Flushing New York 11365
Not listed New York New York 10024
Not listed Rochester New York 14621
Not listed Staten Island New York 10312
Not listed Fargo North Dakota 58104
Not listed Cincinnati Ohio 45236
Not listed Dayton Ohio 45432
Not listed Toledo Ohio 43623
Not listed Collegeville Pennsylvania 19426
Not listed Feasterville Pennsylvania 19053
Not listed Harleysville Pennsylvania 19438
Not listed Warwick Rhode Island 02886
Not listed Austin Texas 78705
Not listed Dallas Texas 75246
Not listed San Antonio Texas 78229
Not listed Midvale Utah 84047
Not listed Salt Lake City Utah 84106
Not listed Virginia Beach Virginia 23451
Not listed Lakewood Washington 98499
Not listed Tacoma Washington 98405
Not listed Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00283842, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2011 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00283842 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →